BMY — Bristol-Myers Squibb Co

Ownership history in OPTIMAS CAPITAL Ltd  ·  3 quarters on record

This page tracks every 13F SEC filing in which OPTIMAS CAPITAL Ltd reported a position in Bristol-Myers Squibb Co (BMY). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
7.29% (2025 Q3)
Avg. % of fund
4.54%
First filed
2024 Q3
Last filed
2025 Q3
Quarters held
3
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 ADDED 255,500 +213,100 +502.6% 7.29% $11.5M $43.97
2024 Q4 REDUCED 42,400 -20,500 -32.6% 3.23% $2.4M $53.25
2024 Q3 INITIATED 62,900 — — 3.09% $3.3M $48.17
% of Fund (quarterly)    BMY price (monthly, adj. close)

Other funds also holding BMY

As of 2025 Q4 — sorted by position size

Birchview Capital, LP 3Y 7Y 9.56% SECTOR GAMMA AS 3Y 7Y 9.17% Independent Franchise Partners LLP 3Y 7Y 7.14% Catalio Capital Management, LP 6.18% FourWorld Capital Management LLC 3Y 4.64% Nepsis Inc. 3Y 7Y 4.57% COLRAIN CAPITAL LLC 3Y 7Y 4.5% BRIDGER MANAGEMENT, LLC 3Y 7Y 3.99% Sofinnova Investments, Inc. 3Y 7Y 3.52% PZENA INVESTMENT MANAGEMENT LLC 3Y 7Y 2.9%
← Back to OPTIMAS CAPITAL Ltd Holdings